Related Experiment Video
Updated: Mar 28, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Clinical Analysis of PTEN, p53 and Her-2/neu Expressions in Thyroid Cancers
Purpose:
The dual-specificity phosphatase PTEN/ MMAC1/TEP1 has recently been identified as the tumor suppressor gene most frequently mutated and/or deleted in human tumors. However, PTEN mutations have rarely been detected in sporadic thyroid cancers. Therefore, this study investigated the PTEN expression of thyroid cancer and the relationship between PTEN, clinical status and other biologic factors such as HER-2/neu and p53.
Materials And Methods:
The study samples consisted of 62 thyroid cancer specimens and 24 benign thyroid tumor specimens from patients who were operated on the Department of Surgery, Uijongbu St. Mary's hospital during the 5 years from January 1995 until January 2000. All tumors were studied by immunohistochemical staining using monoclonal antibodies against PTEN, HER-2/neu and p53. The results were analyzed statistically.
Results:
PTEN protein was found to be under-expressed more frequently in thyroid cancers (29%) than in benign thyroid tumors (4.2%). The reduction in PTEN expression in thyroid cancers was not significantly related with the recorded clinical factors such as size, age, lymph node metastasis and p53, except for HER-2 which was found to be significantly related (p=0.001). HER-2 over- expression was noted in thyroid cancer (83.8%) more frequently than in benign tumors (16.7%).
Conclusion:
This study has demonstrated that the under-expression of PTEN protein and the over-expression of HER-2 protein may play a role in the carcinogenesis and development of thyroid cancer.
Insights
Reduced PTEN protein expression and increased HER-2 protein expression are linked to thyroid cancer development. This study analyzed PTEN and HER-2 in thyroid tumors, finding significant correlations with cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The tumor suppressor gene PTEN (Phosphatase and Tensin homolog) is frequently altered in human cancers.
- PTEN alterations are rare in sporadic thyroid cancers, necessitating further investigation into its role.
- Understanding PTEN and HER-2/neu expression is crucial for thyroid cancer pathogenesis.
Purpose of the Study:
- To investigate PTEN protein expression in thyroid cancer.
- To examine the relationship between PTEN expression and clinical factors in thyroid cancer.
- To analyze the correlation of PTEN expression with HER-2/neu and p53 in thyroid cancer.
Main Methods:
- Immunohistochemical staining was performed on 62 thyroid cancer and 24 benign thyroid tumor specimens.
- Monoclonal antibodies against PTEN, HER-2/neu, and p53 were used.
- Statistical analysis was conducted to evaluate the results.
Main Results:
- PTEN under-expression was significantly more frequent in thyroid cancers (29%) compared to benign tumors (4.2%).
- PTEN expression reduction was not significantly related to tumor size, age, lymph node metastasis, or p53 status.
- A significant relationship was found between PTEN under-expression and HER-2 over-expression (p=0.001) in thyroid cancers. HER-2 over-expression was noted in 83.8% of thyroid cancers versus 16.7% of benign tumors.
Conclusions:
- Under-expression of PTEN protein and over-expression of HER-2 protein may contribute to thyroid cancer development.
- These molecular alterations suggest potential roles in thyroid carcinogenesis.
- Further research into PTEN and HER-2 pathways could inform therapeutic strategies for thyroid cancer.
More Related Videos
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...